Kraenkel 2 , S
Main Takeaway While both drugs induce clinically significant weight loss, tirzepatide shows superior efficacy in weight reduction compared to semaglutide
UltraSlim has no reported side effects
standards, and all drugs from the facility are now on Import Alert 66-40/66-41, with production for the U.S
Compared to an average loss of just 0.880.08% of baseline body weight in the placebo group by 104 weeks post-randomization, patients in the semaglutide arm had lost an average of 9.390.09%
Other serious adverse reactions requiring immediate medical assessment include: Severe allergic reactions Call 999 immediately if experiencing difficulty breathing, facial or tongue swelling, widespread rash, or rapid heartbeat Acute kidney injury significantly reduced urine output, swelling of legs or ankles, or confusion (often secondary to severe dehydration from vomiting or diarrhoea) Severe hypoglycaemia particularly in patients taking concurrent diabetes medications